Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioTurnKey is a premier consulting and service organization dedicated to the cell and gene therapy (CGT) industry. The company offers a comprehensive suite of turnkey solutions designed to assist biotechnology firms in navigating the complexities of therapy development and manufacturing. Their expertise spans facility design, process and analytical development, regulatory strategy, and clinical manufacturing oversight. By providing specialized technical and operational support, BioTurnKey enables clients to accelerate the transition of innovative treatments from the laboratory to the clinic. The firm focuses on optimizing production efficiency and ensuring adherence to global quality standards. Their services are particularly valuable for emerging biotechs seeking to establish robust manufacturing footprints without extensive in-house resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioTurnKey.